Halcyon Biotechnologies

Halcyon Mind

Serving

2 Capsule(s)

Per container

Form

capsule-unknown

UPC

865524000413

DSLD

Avoid-flaggedObjective label signals

Flagged excipients

1 avoid · 3 caution

FDA recalls

no recall history

CAERS reports

FDA consumer events

Certifications

none recorded

1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

9 active ingredients

Ingredient	Amount	% DV
Rhodiola rosea root extract Rhodiola	300 mg	—
Alpha GPC Alpha-GPC	200 mg	—
Theacrine	200 mg	—
Total Carbohydrates CarbohydrateUNII · 0	200 mg	—
Bilberry Fruit Extract bilberryUNII · R911H793SU	100 mg	—
Caffeine Anhydrous CaffeineUNII · 3G6A5W338E	100 mg	—
Caffeine UNII · 3G6A5W338E	100 mg	—
Glucuronolactone UNII · XE4Y3016M9	100 mg	—
Huperzine-A HuperzineUNII · 0111871I23	50 mcg	—

Flagged excipients

● AVOIDTitanium Dioxide
color
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
eur-lex.europa.eu →efsa.europa.eu →ecfr.gov →
◐ CAUTIONFD&C Blue #1
color
EU requires 'attention in children' warning per Commission Regulation 1333/2008 Annex III. Limited to specific food categories; capsule-shell use permitted with restrictions.
eur-lex.europa.eu →
◐ CAUTIONFD&C Red #3
color
FDA revoked food/ingested-drug color additive approval for FD&C Red 3 in January 2025 (Docket FDA-2022-C-2886). Manufacturers have until January 2027 (foods) / January 2028 (ingested drugs) to reformulate.
fda.gov →federalregister.gov →
◐ CAUTIONFD&C Red #40
color
EU requires the same 'attention/activity in children' warning label as Yellow 5 per Commission Regulation 1333/2008 Annex III. California enacted a public-school ban effective 2028 (AB 2316, 2024).
eur-lex.europa.eu →leginfo.legislature.ca.gov →

Other ingredients

Gelatin